glp 1 drugs for alcohol GLP-1 receptor agonists the treatment of use disorder Opinion: Be wary of GLP-1

By filling the gaps left by insurance, GoodRx is reducing friction in the system and accelerating speed to therapy so consumers can benefit from these life-changing treatments, she said

Muller TD, Finan B, Bloom SR, et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 25.Inagaki N., Seino Y., Takeda J., Yano H., Yamada Y., Bell G.I., Eddy R.L., Fukushima Y., Byers M.G., Shows T.B., et al

2022 The major difference between these agents lies in canagliflozin, which is less selective for SGLT2 over SGLT1 and is metabolized primarily in the liver (compared to kidneys), and sotagliflozin, which inhibits both SGLT1 and SGLT2